| Financial Year |
March 31 2023 |
| Monetary Funds |
2,478,298,445.61 |
| Held-for-trading Financial Assets |
23,030,276.43 |
| Notes Receivable |
453,481,676.44 |
| Accounts Receivable |
2,440,517,874.22 |
| Advances to Suppliers |
110,790,772.24 |
| Other Receivables |
1,529,026,180.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
54,156,583.41 |
| Dividend Receivable |
-- |
| Inventories |
629,008,613.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
266,388,473.75 |
| Total Current Assets |
8,097,492,670.19 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
2,404,445,098.72 |
| Investment Properties |
-- |
| Fixed Assetes |
1,195,560,452.27 |
| Under-construction Projects |
527,286,338.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
256,010,330.01 |
| R&D expenses |
-- |
| Goodwill |
11,989,336,557.42 |
| Long-Term Deferred and Prepaid Expenses |
428,509,827.24 |
| Deferred Income Tax Assets |
454,531,166.05 |
| Other Non-Current Assets |
1,430,787,568.21 |
| Sub-Total of Non-Current Assets |
26,032,485,873.45 |
| Total Assets |
34,129,978,543.64 |
| Short-Term Loans |
769,602,002.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
154,194,358.72 |
| Accounts Payable |
1,300,475,762.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
210,443,340.44 |
| Taxes Payable |
252,699,740.31 |
| Interest Payable |
-- |
| Dividend Payable |
141,992,400.00 |
| Other payables |
1,184,119,648.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
127,759,130.41 |
| Other Current Liabilities |
11,134,368.77 |
| Sub-Total of Current Liabilities |
4,828,375,420.92 |
| Long-term Loans |
2,881,536,628.98 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
277,629,541.05 |
| Special Payable |
-- |
| Estimatied Liabilities |
33,054,348.92 |
| Deferred Income Tax Liabilities |
118,270,671.40 |
| Other Non-Current Liabilities |
143,186,318.92 |
| Sub-Total of Non-Current Liabilities |
3,623,607,740.46 |
| Total Liabilities |
8,451,983,161.38 |
| Paid-In Capital(Or Share Stock) |
7,452,556,968.00 |
| Capital Surplus |
14,331,689,721.11 |
| Surplus Reserve |
610,396,559.52 |
| LESS:Treasury Stock |
1,587,146,540.79 |
| Undistributed Profits |
3,535,426,163.46 |
| Minority Stockholder's Interest |
1,252,268,826.57 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
24,425,726,555.69 |
| Owner's Equity（Stockholder's Equity） |
25,677,995,382.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,129,978,543.64 |
